Investment Summary

Icos Capital Invests In Abolis

On September 12, 2024, growth capital firm Icos Capital invested in life science company Abolis

Investment Highlights
  • This is Icos Capital’s 3rd transaction in the Life Science sector.
  • This is Icos Capital’s 1st transaction in France.

Investment Summary

Date 2024-09-12
Target Abolis
Sector Life Science
Investor(s) Icos Capital
Deal Type Growth Capital

Target

Abolis

Evry, France
Abolis is delivering high-impact innovations in biotechnologies that supports industries in their transition to a more sustainable production model by building a better future in collaboration with Nature. Abolis provides tailor-made industrial solutions based on natural and modified micro-organisms. Abolis was founded in 2014 and is based in Evry, France.

Search 205,859 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

DESCRIPTION

Icos Capital is a specialist private equity firm focused on investments in clean technology. Icos looks for European companies that offer new, alternative scarce resources (water, energy) and more efficient industrial and consumer products. The firm looks to provide growth capital in the form of minority investments. Icos' target investment size is €1 to €5 million. Icos Capital is headquartered in Rotterdam, Netherlands.


DEAL STATS #
Overall 16 of 16
Sector (Life Science) 3 of 3
Type (Growth Capital) 13 of 13
Country (France) 1 of 1
Year (2024) 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-08-16 PEF Technologies

Enschede, Netherlands

PEF Technologies offers a wide range of food processing equipment for various needs of businesses of any level of production. PEF Technologies's nanoPEF is a completely new low-temperature food preservation technology. PEF Technologies was founded in 2018 and is based in Enschede, Netherlands.

Buy -